HUT enters the week in an extraordinary position: a 33% price surge in five days, a wave of analyst upgrades still lagging the move, and a short base that has been quietly unwinding.
The story this week is entirely analyst-driven. Eight firms raised their price targets in the space of a week — every single one maintained a Buy or equivalent rating while doing so. The size of the moves is striking. B. Riley lifted its target from $76 to $130 on May 13. Canaccord moved from $70 to $130. Citizens went from $100 to $140. Needham from $88 to $128. Most of these revisions followed Hut 8's Q1 earnings on May 6, which delivered a 25.7% single-day gain and, in the prior quarter, a 39.5% one-day move with a 37.4% five-day follow-through. The consensus mean target now clusters around $109–$130, with the stock closing at $107.31 — meaning the Street is broadly neutral on near-term upside after the run, even after the aggressive re-ratings. The EPS surprise factor score ranks in the 95th percentile, which goes some way to explaining why analysts keep having to chase the print.
Short sellers are losing ground but have not capitulated. Short interest has fallen to 19.2% of the free float, down from a recent peak near 20.9% in late April — a meaningful decline, but still a substantial structural short. The borrow market offers no squeeze signal to speak of. The cost to borrow is a negligible 0.47%, and availability in the lending pool is ample, with lending utilization at just 12% of available shares — a dramatic loosening from the 27% range seen in early April and well off the 52-week high of 62%. That combination tells a consistent story: shorts are covering methodically as the stock rallies, not being forced out. The ORTEX short score has eased from 59.1 on May 6 to 54.4 today, moving away from elevated territory as the short-side pressure gradually dissipates.
Options positioning has shifted more cautious in the wake of the rally. The put/call ratio moved to 0.66, above its 20-day average of 0.56 by about 1.4 standard deviations — not extreme, but noticeably more hedged than the mid-April lows below 0.50. The 52-week PCR high is 0.79, so there is room for further defensiveness to build. The pattern is consistent with investors who rode the earnings gap now buying protection rather than adding to long exposure at elevated levels.
The bull case leans on Hut 8's pivot toward AI and high-performance compute infrastructure. The long-term River Bend campus contract, cited as validation of a power-first development model, gives the revenue visibility argument legs. The bear case is harder to dismiss at current prices: the stock is loss-making at the net income level, carries $2 billion in net debt, and derives a material share of its economics from Bitcoin — a market it cannot control. The EV/EBITDA multiple, on consensus estimates, is running at a level that implies near-perfection in execution. Lone Pine Capital's filing of a 5.5% stake, alongside Coatue at 8.1% and Vanguard adding 1.15 million shares last quarter, gives the institutional base credibility — but those positions were built at much lower prices.
The next formal catalyst is the Q2 earnings call set for June 11. Between now and then, the degree to which short covering continues — or stalls — as the stock consolidates above the analyst consensus range will be the clearest indicator of whether the recent move has resolved the positioning tension or merely deferred it.
See the live data behind this article on ORTEX.
Open HUT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
